<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111929</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Chagas' disease and kidney donation</dc:title>
<dc:description xml:lang="en">Due to current trends in human population movements, there has been an increase in the number of individuals with Chagas' disease (CD) living in non-endemic regions; as such, there is a high probability that we will face an increase in cases of CD, both in patients requiring renal replacement therapy and in potential donors. We present the case of an organ donor with positive serology for Trypanosoma cruzi, whose kidneys were implanted into two different recipients. Prophylaxis was administered with benznidazole for 3 weeks. Over the course of two years of serological and clinical follow-up, no evidence of Chagas' transmission or infection was observed. This positive evolution suggests that renal transplants derived from donors with positive serology results and no signs of acute or chronic disease may be acceptable. We also provide a review of the evidence supporting this conclusion and the available recommendations in the medical literature (AU)</dc:description>
<dc:creator>Quintana, Salvador</dc:creator>
<dc:creator>Crespo, Marta</dc:creator>
<dc:creator>Pascual, Julio</dc:creator>
<dc:creator>Márquez, Eva</dc:creator>
<dc:creator>Barbosa, Francesc</dc:creator>
<dc:creator>Pérez-Sáez, María J</dc:creator>
<dc:creator>Mir, Marisa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Debido a los movimientos poblacionales que se desarrollan actualmente, existe un incremento en el número de individuos con enfermedad de Chagas (EC) que viven en regiones no endémicas; por tanto, existe una gran probabilidad de que nos enfrentemos a un aumento de casos de EC, tanto en pacientes que requieren tratamiento renal sustitutivo como en potenciales donantes. Presentamos el caso de un donante de órganos con serología Trypanosoma cruzi positiva, cuyos riñones se implantaron en sendos receptores. Se realizó profilaxis con benznidazol durante 3 semanas. En dos años de seguimiento serológico y clínico no se ha objetivado ninguna evidencia de transmisión ni afectación chagásica. La buena evolución sugiere que el trasplante de riñones procedentes de donantes con serología positiva sin signos de enfermedad aguda o crónica puede ser aceptable. Revisamos las evidencias que lo sustentan y las recomendaciones disponibles en la literatura (AU)</dc:description>
<dc:source>Nefrologia;33(1): 128-133, ene.-feb. 2013. tab</dc:source>
<dc:identifier>ibc-111929</dc:identifier>
<dc:title xml:lang="es">Enfermedad de Chagas y donación renal</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d38812^s22045</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29475^s22020</dc:subject>
<dc:subject>^d31085^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d30425^s22080</dc:subject>
<dc:subject>^d14408^s22083</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201302</dc:date>
</metadata>
</record>
</ibecs-document>
